Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2011 (2011), Article ID 269853, 8 pages
http://dx.doi.org/10.1155/2011/269853
Review Article

Intrauterine Growth Retardation and Nonalcoholic Fatty Liver Disease in Children

1Liver Research Unit, Bambino Gesù Children's Hospital and Research Institute, 00165 Rome, Italy
2Department of Maternal and Pediatric Sciences, Fondazione IRCCS Ca' Granda—Ospedale Maggiore Policlinico, University of Milan, 20122 Milan, Italy

Received 27 July 2011; Accepted 11 October 2011

Academic Editor: Daniela Jezova

Copyright © 2011 Anna Alisi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “WHO report: reducing risks, promoting healthy life,” Geneva, Switzerland, World Health Organization, 2002.
  2. D. J. P. Barker, C. N. Hales, C. H. D. Fall, C. Osmond, K. Phipps, and P. M. S. Clark, “Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth,” Diabetologia, vol. 36, no. 1, pp. 62–67, 1993. View at Publisher · View at Google Scholar
  3. A. T. Hattersley and J. E. Tooke, “The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease,” Lancet, vol. 353, no. 9166, pp. 1789–1792, 1999. View at Publisher · View at Google Scholar
  4. K. Haram, E. Svendsen, and O. Myking, “Growth restriction: etiology, maternal and neonatal outcome. A review,” Current Women's Health Reviews, vol. 3, no. 3, pp. 145–160, 2007. View at Publisher · View at Google Scholar
  5. G. Valsamakis, C. Kanaka-Gantenbein, A. Malamitsi-Puchner, and G. Mastorakos, “Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome,” Annals of the New York Academy of Sciences, vol. 1092, pp. 138–147, 2006. View at Publisher · View at Google Scholar · View at PubMed
  6. A. Alisi, S. Cianfarani, M. Manco, C. Agostoni, and V. Nobili, “Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment,” Annals of Medicine. In press.
  7. V. Nobili, A. Alisi, N. Panera, and C. Agostoni, “Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review,” Pediatric Endocrinology Reviews, vol. 6, no. 2, pp. 241–247, 2008. View at Google Scholar
  8. I. Brandt, E. J. Sticker, and M. J. Lentze, “Catch-up growth of head circumference of very low birth weight, small for gestational age preterm infants and mental development to adulthood,” Journal of Pediatrics, vol. 142, no. 5, pp. 463–468, 2003. View at Publisher · View at Google Scholar · View at PubMed
  9. A. Singhal, M. Fewtrell, T. J. Cole, and A. Lucas, “Low nutrient intake and early growth for later insulin resistance in adolescents born preterm,” Lancet, vol. 361, no. 9363, pp. 1089–1097, 2003. View at Publisher · View at Google Scholar · View at PubMed
  10. Z. Ergaz, M. Avgil, and A. Ornoy, “Intrauterine growth restriction - Etiology and consequences: what do we know about the human situation and experimental animal models?” Reproductive Toxicology, vol. 20, no. 3, pp. 301–322, 2005. View at Publisher · View at Google Scholar · View at PubMed
  11. G. P. Mandruzzato, “Intrauterine growth restriction (IUGR): guidelines for definition, recognition and management,” Archives of Perinatal Medicine, vol. 14, pp. 7–8, 2008. View at Google Scholar
  12. A. K. Deorari, R. Agarwal, and V. K. Paul, “Management of infants with intra-uterine growth restriction,” Indian Journal of Pediatrics, vol. 75, no. 2, pp. 171–174, 2008. View at Publisher · View at Google Scholar
  13. T. N. Leung, C. W. K. Lam, K. F. To, and C. J. Haines, “Changes in concentrations of lipoprotein (a) and other lipids and lipoproteins in pregnancies complicated by pregnancy-induced hypertension or intrauterine growth retardation,” Hypertension in Pregnancy, vol. 17, no. 2, pp. 157–168, 1998. View at Google Scholar
  14. M. Weinstock, “The potential influence of maternal stress hormones on development and mental health of the offspring,” Brain, Behavior, and Immunity, vol. 19, no. 4, pp. 296–308, 2005. View at Publisher · View at Google Scholar · View at PubMed
  15. N. Hendrix and V. Berghella, “Non-Placental Causes of Intrauterine Growth Restriction,” Seminars in Perinatology, vol. 32, no. 3, pp. 161–165, 2008. View at Publisher · View at Google Scholar · View at PubMed
  16. H. D. McIntyre, R. Serek, D. I. Crane et al., “Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 3, pp. 1143–1150, 2000. View at Publisher · View at Google Scholar
  17. I. Cetin and G. Alvino, “Intrauterine growth restriction: implications for placental metabolism and transport. A review,” Placenta, vol. 30, pp. 77–82, 2009. View at Publisher · View at Google Scholar · View at PubMed
  18. L. Myatt, W. Kossenjans, R. Sahay, A. Eis, and D. Brockman, “Oxidative stress causes vascular dysfunction in the placenta,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 9, no. 1, pp. 79–82, 2000. View at Google Scholar
  19. M. G. Ross and M. H. Beall, “Adult sequelae of intrauterine growth restriction,” Seminars in Perinatology, vol. 32, no. 3, pp. 213–218, 2008. View at Publisher · View at Google Scholar · View at PubMed
  20. P. D. Gluckman, M. A. Hanson, and C. Pinal, “The developmental origins of adult disease,” Maternal and Child Nutrition, vol. 1, no. 3, pp. 130–141, 2005. View at Publisher · View at Google Scholar · View at PubMed
  21. D. D. Mcintire, S. L. Bloom, B. M. Casey, and K. J. Leveno, “Birth weight in relation to morbidity and mortality among newborn infants,” New England Journal of Medicine, vol. 340, no. 16, pp. 1234–1238, 1999. View at Publisher · View at Google Scholar
  22. D. J. P. Barker, “Maternal nutrition, fetal nutrition, and disease in later life,” Nutrition, vol. 13, no. 9, pp. 807–813, 1997. View at Publisher · View at Google Scholar
  23. D. D. Briana and A. Malamitsi-Puchner, “Intrauterine growth restriction and adult disease: the role of adipocytokines,” European Journal of Endocrinology, vol. 160, no. 3, pp. 337–347, 2009. View at Publisher · View at Google Scholar · View at PubMed
  24. C. Lévy-Marchal and P. Czernichow, “Small for gestational age and the metabolic syndrome: which mechanism is suggested by epidemiological and clinical studies?” Hormone Research, vol. 65, no. 3, pp. 123–130, 2006. View at Publisher · View at Google Scholar · View at PubMed
  25. C. N. Hales and D. J. P. Barker, “The thrifty phenotype hypothesis,” British Medical Bulletin, vol. 60, pp. 5–20, 2001. View at Publisher · View at Google Scholar
  26. L. Nair, M. K. Nair, and D. S. Chacko, “Markers of fetal onset adult diseases,” Indian pediatrics, vol. 46, pp. s48–s54, 2009. View at Google Scholar
  27. D. Jaquet, A. Gaboriau, P. Czernichow, and C. Levy-Marchal, “Insulin resistance early in adulthood in subjects born with intrauterine growth retardation,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 4, pp. 1401–1406, 2000. View at Publisher · View at Google Scholar
  28. A. T. Hattersley, F. Beards, E. Ballantyne, M. Appleton, R. Harvey, and S. Ellard, “Mutations in the glucokinase gene of the fetus result in reduced birth weight,” Nature Genetics, vol. 19, no. 3, pp. 268–270, 1998. View at Publisher · View at Google Scholar · View at PubMed
  29. D. Jaquet, J. Leger, P. Czernichow, and C. Levy-Marchal, “The effect of in-utero undernutrition on the insulin resistance syndrome,” Current diabetes reports, vol. 2, no. 1, pp. 77–82, 2002. View at Google Scholar
  30. N. Soto, R. A. Bazaes, V. Peña et al., “Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 8, pp. 3645–3650, 2003. View at Publisher · View at Google Scholar
  31. A. C. S. Hokken-Koelega, W. J. De Waal, T. C. J. Sas, Y. Van Pareren, and N. J. T. Arends, “Small for gestational age (SGA): endocrine and metabolic consequences and effects of growth hormone treatment,” Journal of Pediatric Endocrinology and Metabolism, vol. 17, no. 3, pp. 463–469, 2004. View at Google Scholar
  32. L. Ibáñez, L. Suárez, A. Lopez-Bermejo, M. Díaz, C. Valls, and F. De Zegher, “Early development of visceral fat excess after spontaneous catch-up growth in children with low birth weight,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 3, pp. 925–928, 2008. View at Publisher · View at Google Scholar · View at PubMed
  33. A. Vaag, C. Bjørn Jensen, P. Poulsen et al., “Metabolic aspects of insulin resistance in individuals born small for gestational age,” Hormone Research, vol. 65, no. 3, pp. 137–143, 2006. View at Publisher · View at Google Scholar · View at PubMed
  34. D. Jaquet, S. Deghmoun, D. Chevenne, D. Collin, P. Czernichow, and C. Lévy-Marchal, “Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth,” Diabetologia, vol. 48, no. 5, pp. 849–855, 2005. View at Publisher · View at Google Scholar · View at PubMed
  35. S. Tenhola, A. Martikainen, E. Rahiala, E. HerrgÅrd, P. Halonen, and R. Voutilainen, “Serum lipid concentrations and growth characteristics in 12-year-old children born small for gestational age,” Pediatric Research, vol. 48, no. 5, pp. 623–628, 2000. View at Google Scholar
  36. E. M. Brunt, “Pathology of fatty liver disease,” Modern Pathology, vol. 20, no. 1, pp. S40–S48, 2007. View at Publisher · View at Google Scholar · View at PubMed
  37. M. M. Yeh and E. M. Brunt, “Pathology of nonalcoholic fatty liver disease,” American Journal of Clinical Pathology, vol. 128, no. 5, pp. 837–847, 2007. View at Publisher · View at Google Scholar · View at PubMed
  38. A. Alisi, M. Manco, A. Vania, and V. Nobili, “Pediatric nonalcoholic fatty liver disease in 2009,” Journal of Pediatrics, vol. 155, no. 4, pp. 469–474, 2009. View at Publisher · View at Google Scholar · View at PubMed
  39. J.-F. Fu, H.-B. Shi, L.-R. Liu et al., “Non-alcoholic fatty liver disease: an early mediator predicting metabolic syndrome in obese children?” World Journal of Gastroenterology, vol. 17, no. 6, pp. 735–742, 2011. View at Publisher · View at Google Scholar · View at PubMed
  40. H. Tilg and A. R. Moschen, “Insulin resistance, inflammation, and non-alcoholic fatty liver disease,” Trends in Endocrinology and Metabolism, vol. 19, no. 10, pp. 371–379, 2008. View at Publisher · View at Google Scholar · View at PubMed
  41. A. Alisi, M. Locatelli, and V. Nobili, “Nonalcoholic fatty liver disease in children,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 13, no. 4, pp. 397–402, 2010. View at Publisher · View at Google Scholar · View at PubMed
  42. G. Baffy, “Kupffer cells in non-alcoholic fatty liver disease: the emerging view,” Journal of Hepatology, vol. 51, no. 1, pp. 212–223, 2009. View at Publisher · View at Google Scholar · View at PubMed
  43. N. Mendez-Sanchez, M. Arrese, D. Zamora-Valdés, and M. Uribe, “Current concepts in the pathogenesis of nonalcoholic fatty liver disease,” Liver International, vol. 27, no. 4, pp. 423–433, 2007. View at Publisher · View at Google Scholar · View at PubMed
  44. E. W. Kraegen and G. J. Cooney, “Free fatty acids and skeletal muscle insulin resistance,” Current Opinion in Lipidology, vol. 19, no. 3, pp. 235–241, 2008. View at Publisher · View at Google Scholar · View at PubMed
  45. J. L. Morrison, J. A. Duffield, B. S. Muhlhausler, S. Gentili, and I. C. McMillen, “Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity,” Pediatric Nephrology, vol. 25, no. 4, pp. 669–677, 2010. View at Publisher · View at Google Scholar · View at PubMed
  46. C. F. Rueda-Clausen et al., “Hypoxia-induced intrauterine growth restriction increases the susceptibility of rats to high-fat diet-induced metabolic syndrome,” Diabetes, vol. 60, pp. 507–516, 2011. View at Google Scholar
  47. T. R. Magee, G. Han, B. Cherian, O. Khorram, M. G. Ross, and M. Desai, “Down-regulation of transcription factor peroxisome proliferator-activated receptor in programmed hepatic lipid dysregulation and inflammation in intrauterine growth-restricted offspring,” American Journal of Obstetrics and Gynecology, vol. 199, no. 3, pp. 271–e1, 2008. View at Publisher · View at Google Scholar · View at PubMed
  48. V. Nobili, G. Bedogni, A. Alisi et al., “A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease,” Archives of Disease in Childhood, vol. 94, no. 10, pp. 801–805, 2009. View at Publisher · View at Google Scholar · View at PubMed